Novartis enters agreement to acquire Mariana Oncology, …

Basel, May 2, 2024 – Novartis today announced that it has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, …

CouponFollow Extension

$1
OFF

Novartis To Buy Mariana Oncology For $1B Upfront (NYSE:NVS)

4 weeks from now

May 2, 2024 · Novartis (NYSE:NVS) has agreed to acquire cancer drugmaker Mariana Oncology for an upfront payment of $1B and an additional $750M in milestone payments.The …

seekingalpha.com

$1
OFF

Novartis To Buy Mariana Oncology In Radiopharmaceutical Expansion

4 weeks from now

May 2, 2024 · Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it has agreed to pay $1 billion to acquire biotechnology company Mariana Oncology. …

yahoo.com

$1
OFF

Novartis Buys Mariana Oncology In $1B Acquisition, Bolsters

4 weeks from now

May 2, 2024 · Novartis pushed deeper into radioligand therapy Thursday, announcing a $1 billion buyout that will give it control of Mariana Oncology ’s preclinical cancer pipeline and clinical …

biospace.com

$1.75
OFF

Novartis To Buy Mariana Oncology For Up To $1.75 Billion In Boost …

4 weeks from now

May 2, 2024 · Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and efforts to develop …

morningstar.com

$1
OFF

Novartis To Buy Mariana Oncology, Paying $1 Billion Upfront (1)

4 weeks from now

May 2, 2024 · Novartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can specifically target cancer cells.. The Swiss company said Thursday it will pay …

bloomberglaw.com

$1
OFF

Mariana Oncology To Be Acquired By Novartis For $1 Billion …

4 weeks from now

May 2, 2024 · The Life Sciences team advised Mariana Oncology on its acquisition by Novartis for $1 billion upfront and up to $750 million in potential milestone payments. The acquisition …

goodwinlaw.com

$1
OFF

Novartis Extends Radiopharma Plans With $1 Billion Acquisition

4 weeks from now

May 2, 2024 · Novartis is paying $1 billion upfront and up to an additional $750 million if certain milestones are met to acquire startup Mariana Oncology, the latter company announced …

statnews.com

$1.75
OFF

Novartis Digs Deeper In Radiopharma With $1.75bn Mariana Buy

4 weeks from now

3 days ago · Novartis has struck another deal to strengthen its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology. …

pharmaphorum.com

$1
OFF

Novartis Entrenches Into Radiopharma With $1B Mariana Buy

4 weeks from now

May 2, 2024 · With much still to discover in the massive world of radiopharmaceuticals, Novartis will take a deep dive into the unknown with Mariana Oncology in a $1 billion upfront acquisition.

fiercebiotech.com

$1.75
OFF

Novartis To Buy Mariana Oncology For Up To $1.75 Billion In Boost …

4 weeks from now

May 2, 2024 · By Mauro Orru Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and …

marketscreener.com

$1
OFF

Novartis-Mariana Oncology Deal Drives Radiopharma (NYSE:NVS)

4 weeks from now

May 2, 2024 · Radiopharma stocks gained after Novartis (NVS) agreed to acquire Mariana Oncology, expanding its radiopharmaceutical portfolio for $1B upfront. Read more here.

seekingalpha.com

$1
OFF

Novartis To Buy Mariana Oncology, Pay $1 Billion Upfront

4 weeks from now

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by …

marketscreener.com

FAQs about Novartis enters agreement to acquire Mariana Oncology, … Coupon?

Will Novartis pay $1 billion to buy Mariana oncology?

Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it has agreed to pay $1 billion to acquire biotechnology company Mariana Oncology. Mariana, which specializes in the targeted radiation medicines, could receive up to $750 million more from Novartis if certain milestones are met. ...

What's new at Mariana oncology?

This journey has brought us to a new name: We are now Mariana Oncology Check back here for the latest on Mariana Oncology. Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion ...

How much does Novartis pay upfront?

The Swiss company said Thursday it will pay $1 billion upfront for the Watertown, Massachusetts-based firm, with an additional $750 million of milestone payments if certain targets are reached. The deal adds to a Novartis portfolio of targeted radioactive therapies that’s led by Pluvicto, a prostate cancer treatment. ...

Are Novartis & Mariana's cancer pipelines overlapping?

The pipelines are not overlapping despite being squarely in the same modality of radiopharmaceuticals. Novartis’ Pluvicto and Lutathera are approved for prostate cancer and neuroendocrine tumors, respectively, while Mariana’s pipeline tackles a wider range of tumor types and targets. ...

Who is Mariana oncology?

Based in Watertown, Massachusetts, Mariana Oncology is a preclinical-stage biotechnology company focused on developing RLTs to treat cancers with high unmet need. ...

What is Mariana oncology worth?

Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion ...